AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2018 Issue 4; New/Revised ICD-10-PCS Codes
New Therapeutic Substances
Two new Substance values were added to code table XW0, Anatomical Regions, Introduction, as follows: Device/Substance/TechnologyG Plazomicin Anti-Infective H Synthetic Human Angiotensin II Plazomicin Plazomicin is a next-generation aminoglycoside antibiotic developed to treat serious bacterial infections due to multidrug-resistant (MDR) gram-negative Enterobacteriaceae including carbapenem-resistant Enterobacteriaceae (CRE). Two indications are being sought for plazomicin: complicated urinary tract infection, including pyelonephritis, and bloodstream infections due to certain MDR Enterobacteriaceae. Plazomicin is expected to be reserved for use in the treatment of patients diagnosed with these types of infections who have limited or no alternative treatment options, and would be used only...
Subscribe or sign in to view the full article.
Article Overview
This article is a coding update focused on newly added therapeutic substance values in an ICD-10-PCS table for anatomical regions and introduction. It explains the clinical context for the substances, including their intended therapeutic areas and the patient populations or conditions they are associated with. The article is useful for coders, CDI specialists, compliance staff, and other healthcare professionals who track ICD-10-PCS updates and need to understand the scope of the change at a high level.
Why This Topic Matters
Updates to ICD-10-PCS tables can affect how procedures and related therapeutic substances are represented in coded data. This article helps readers recognize the scope of the update and the clinical scenarios tied to the newly added substances without relying on the full premium text.
What You Will Learn
- Which ICD-10-PCS table received new therapeutic substance values
- The broad clinical settings associated with the newly added substances
- How the article frames the update in relation to infection treatment and shock management
- Why these additions may matter to coding and documentation review workflows
Who Should Read This
- Medical coders
- Coding auditors
- Clinical documentation integrity specialists
- Compliance professionals
- Revenue cycle staff
- Healthcare data analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com